Dietary flaxseed (FS) is a nutritional whole grain with high contents of omega-3 fatty acids and lignans with anti-inflammatory and antioxidant properties. We evaluated FS in a murine model of pulmonary ischemia/reperfusion injury (IRI) by dietary supplementation of 0% (control) or 10% (treatment) FS prior to IRI. Mice fed 0% FS undergoing IRI had a significant decrease in arterial oxygenation (PaO 2 ) and a significant increase in bronchoalveolar lavage (BAL) protein compared to sham operated mice.
INTRODUCTION
The lung is a major target of oxidant stress. Several pulmonary diseases including adult respiratory distress syndrome (ARDS) and post-lung transplantation graft dysfunction have been associated with an imbalance in the pro-oxidant versus antioxidant state of the lung (20) .
Ischemia/reperfusion injury (IRI) is an important cause of early graft failure in the immediate postoperative period and accounts for the about 15% of all cases with high mortality (13) Antioxidant nutrients have been implicated in the protection against lung diseases such as chronic obstructive pulmonary disease (21) , ARDS, and asthma (43) . ARDS patients have significantly lowered plasma levels of vitamins E and C, and of ß-carotene and selenium (34) , thought to be an indication that the antioxidative system in these patients is compromised. Gadek et al. (17, 36) investigated the role of dietary supplementation of antioxidant nutrients and polyunsaturated fatty acids in patients with sepsis-induced ARDS and showed that enteral feeding of antioxidants improved lung microvascular permeability, oxygenation, and cardiopulmonary function.
Flaxseed (FS), a whole grain used as a nutritional supplement, has gained popularity because it is a rich source of natural antioxidants. FS has high concentrations of omega-3 fatty acids and lignans.
Omega-3 fatty acids reduce inflammation and may be helpful in treating a variety of autoimmune diseases (28, 45) . Lignans, widely occurring plant compounds, are closely related to lignin and possess antioxidant properties (49) . Secoisolariciresinol diglucoside (SDG), isolated from FS, is metabolized in the mammalian intestine to the lignans enterodiol (ED) and enterolactone (EL). The oxygen radical scavenging properties of the FS lignans have been shown in vitro to act either by direct hydroxyl radical scavenging activity (38, 39) or by inhibition of lipid peroxidation (26) . The antioxidant properties of FS lignans have been verified in animal models of endotoxic shock (37) , diabetes (40) and in carbon tetrachloride-induced oxidative stress (32) . Although ROS production and oxidant stress have been implicated in the etiology of acute and chronic lung injury, the therapeutic or preventative use of dietary FS or FS-derived lignans has not been extensively evaluated in pulmonary disease.
Our group recently investigated FS in the context of a variety of acute lung injuries and showed that FS protects against injury induced by hyperoxia and acid-aspiration (24) . In the current study, we hypothesized that dietary FS supplementation could provide antioxidant protection in a murine model of pulmonary oxidant stress resulting from IRI. This model mimics the effects of IRI seen in lung transplantation, major pulmonary resections, and other clinically relevant procedures such as cardiopulmonary bypass. We hypothesize that FS may be protective in IRI by enhancing antioxidant defenses, specifically through decreased ROS generation and increased ROS detoxification. We examined the former using an ex vivo model of normoxic ischemia and in vitro models to allow measurement of ROS generation by pulmonary alveolar macrophages and endothelial cells in response to oxidative burst and cessation of flow. We investigated the possibility of increased ROS detoxification in two ways: evaluating for direct detoxification by ROS scavenging in vitro, and assessing for indirect detoxification through the upregulation of endogenous antioxidant and cytoprotective enzymes in the lungs of FS fed mice. We concentrated on the transcription factor nuclear factor-E2-related factor-2 (Nrf2), shown to be a master regulator of the antioxidant promoter response element (ARE) that encodes antioxidant and cytoprotective enzymes. Plant lignans, aside from having inherent antioxidant properties, 
MATERIALS AND METHODS

Animals
Female C57Bl/6 mice of ages 6-8 weeks (Charles River, Wilmington, MA) were used. Animals were cared for and housed at the Children's Hospital of Philadelphia animal facility (Philadelphia, PA).
All protocols were performed in accordance with National Institutes of Health guidelines and with the approval of the CHOP and the University of Pennsylvania Animal Use Committees (IACUC).
Diets and dietary treatments
Semi-purified AIN-93G diet was used as the base diet (41) , which was supplemented with 10%
(w/w) FS as prepared by Purina Mills (Test Diet, Bloomsburg, IN) (4). Isocaloric control and treatment diets were formulated as described previously (24) from whole ground FS kindly provided by Dr. Jack
Carter (North Dakota State University, Fargo, ND). Mice were fed with control or treatment diet for at least three weeks prior to experimental intervention.
In vivo model of lung IRI
A mouse model of IRI was adopted from a rat model (14 
Ex vivo mouse model of lung IRI and imaging of ROS
The isolated perfused lung technique used for this study has been described previously for rat lungs (16) and was modified for mouse lungs (51). For details, see online supplementary materials and methods. Briefly, heart-lung preparations were dissected en bloc from mice fed FS or control diets, and the trachea and pulmonary artery were cannulated for connection to a ventilator and peristaltic pump, respectively. Imaging studies were carried out with an epifluorescence microscope and the subpleural vasculature was imaged using fluorophores and MetaMorph imaging software (Universal Imaging, West
Chester, PA). Global ischemia and reperfusion were produced with manipulation of flow. Ventilation was continued throughout the entire operation to maintain normoxia. For each experiment, lavages obtained from 4-6 mice were used and 8-10 fields imaged for each preparation. For each condition, 6-8 fields were randomly selected for fluorescence quantification.
ROS generation in response to ischemia/reperfusion by pulmonary microvascular endothelial cells (PMVEC) incubated with FS lignans
We used a flow adaptation chamber (Warner Instruments Inc.) to simulate ischemia/reperfusion conditions in vitro as described (3, 33) . Briefly, PMVEC on slides are inserted into a chamber with in- Experiments employing FS lignans were conducted using analytical grade mammalian lignans (Chromadex, Santa Ana, CA).
Imaging and quantification of fluorescence
Metamorph Imaging Software (MDS, Toronto) was used for image processing on a preset scale of arbitrary units ranging from 0 to 4095. All images were processed to the same scale and the average intensity of each field was obtained. Data from multiple fields as indicated over several experiments was used to obtain the final results.
Western blotting for NQO-1, HO-1, and Nrf2
Mice were fed whole grain FS at 0%, 5%, or 10% up to three weeks prior to immunoblot analysis on whole lung homogenates as previously described by Tliba et al. (47) . Primary antibodies used: HO-1 (Stressgen, San Diego, CA), NQO-1 (Novus Biologicals, Littleton, CO), and an affinitypurified rabbit polyclonal anti-Nrf2 antibody raised against a 16 AA peptide at the amino-terminus of mouse Nrf2 (clone MCS-1, Rockland Immunochemicals, Gilbertsville, PA). Densitometry of western blots with -actin normalization of expression was performed using Gel-Pro Analyzer (Version 6.0, MediaCybernetics, Silver Spring, MD). Cell culture PMVEC were isolated from murine lungs as described (3) . Briefly, freshly harvested mouse lungs were treated with collagenase followed by isolation of cells by adherence to magnetic beads coated with mAb to platelet endothelial cell adhesion molecule.
Lactate dehydrogenase (LDH) release assay
LDH release was measured using a commercial assay (Cytotoxicity Detection Kit, Roche
Applied Science, Indianapolis, IN) to evaluate cell damage and cytotoxicity according to manufacturer's instructions (27) . Briefly, PMVEC were seeded in a 96-well plate and ED added (10-200 µM)
simultaneously with oxidative challenge (1mM H 2 O 2 ) for a designated time. Percentage cytotoxicity was calculated.
Statistical Analysis
Results are expressed as means ± SEM for three or more independent experiments. Significance was determined using ANOVA or Student's t-test as appropriate using R and Stata 7.0 (Stata Corporation, College Station, TX). Statistical significance was defined as p < 0.05. 
DISCUSSION
This study presents novel findings that flaxseed (FS), a nutritional supplement with antioxidant and anti-inflammatory properties, can be used to ameliorate acute lung injury in a murine model of ischemia/reperfusion injury (IRI). The deleterious physiologic effects and oxidative damage that results from IRI were abrogated in mice prefed a diet supplemented with whole grain FS. We also show that FS has potentially multiple mechanisms of action to affect this improvement through both reduced ROS generation and increased ROS detoxification.
We developed a murine model of IRI (60 minutes ischemia/60 minutes reperfusion) that causes significant hypoxemia and lung injury. These changes were ameliorated to a significant degree when mice were prefed diets supplemented with whole grain FS for at least 3 weeks. Admittedly, the short reperfusion time is a limitation and, thus, the possibility of a frame shift cannot be excluded. To fully elucidate this would require progressively extending IR times until no protective effect is observed. We are in the process of refining our in vivo procedure to allow for this set of experiments.
To explore the mechanisms of how FS may be ameliorating IRI in our model, we hypothesized that FS supplementation could be acting by decreasing ROS generation and/or increasing ROS detoxification. To investigate the former, we employed an ex vivo model of normoxic ischemia. In an in vitro model evaluating ROS development after oxidative burst stimulated by FMLP, alveolar macrophages isolated from mice prefed 10% FS generated a significantly lower amount of ROS as measured by fluorescence using H 2 DCFDA and Amplex Red dyes. A significant decrease in superoxide generation was also observed. This is direct evidence that cellular mediators of inflammation and first responders to oxidative stress in the lung are altered or "primed" to respond to a significant oxidative challenge after FS feeding. While the exact mechanism of the effect of FS on alveolar macrophages is not clear, altered function or assembly of the NADPH oxidase complex --also present on macrophages --may similarly be implicated.
We further evaluated ROS generation in an in vitro model of ischemia/reperfusion using flow adaptation chambers populated with PMVEC, with or without preincubation with the FS lignan ED.
PMVEC were utilized to reproduce the pulmonary endothelial environment directly exposed to ROS during anoxia and subsequent re-oxygenation (48) . We observed ROS generation by flow adapted PMVEC undergoing ischemia/reperfusion to be significantly decreased after preincubation with ED.
Given evidence that HO-1 is protective in several models of acute lung injury (7) Activation of the Nrf2/ARE pathway in response to FS supplementation was investigated. The
Nrf2 transcription factor regulates the ARE which is present in the 5' regulatory region of genes encoding Phase II cytoprotective and detoxifying enzymes. Nrf2 knockout mice are more susceptible to lung injury induced by butylated hydroxytoluene (2) and hyperoxia (5, 6) . In a recent study by Leonard et al., Nrf2 and several Nrf2 controlled antioxidant genes were upregulated upon reoxygenation in a renal model of ischemia/reperfusion in mice, a process that appears to be dependent on ROS signaling (31) . The Nrf2-regulated enzyme HO-1 has been well studied and characterized as a graft survival gene in heart and liver transplantation (18, 50) .
In this study, we demonstrated for the first time that in a dose and time dependent manner, mice suggested by recent work by Datla et al. (12) . They showed that HO-1 induction caused by suppression of NADPH oxidase activity was reversed with the HO-1 inhibitor tin protoporphyrin-IX, suggesting a multimodal role for HO-1 induction by FS ingestion in the current study.
We cannot categorically state that the upregulation of phase II enzymes such as HO-1 is the sole mechanism by which FS protects against the oxidative effects of IRI in these studies. FS may induce the expression of multiple genes other than those regulated by Nrf2 and affect other cell processes that result in increased ROS upon reperfusion such as protease activation or decreases in tight junction integrity (13) . This remains a limitation of the current study. However, our finding that phase II enzyme induction is associated with a reduction of the effects of IRI certainly suggests that it is a likely, if not unique, mechanism by which FS exerts its effects in our model.
The mechanism by which FS increases Nrf2 expression and/or activity is being investigated by recently showed that the flavonoid heracetin diglucoside was unexpectedly a substructure of the lignan macrocolecule derived from FS hulls (46) . FS therefore may be acting as a mild electrophile to induce nuclear localization of Nrf2 and ARE activation in the mouse lung. This suggests that the increase in antioxidant properties of the lung may be a cellular response to mild oxidative stress subsequent to FS feeding. Similar effects are seen with sulforaphane, curcumin, and other dietary Phase II enzyme inducers (42, 44 ). This observation is in agreement with recent reports that demonstrate that ROS at low levels can serve as second messengers in cells to affect physiological redox signaling, which in turn may lead to the activation of cellular defense systems. This is adaptive signaling, and the phase II genes are isolated and formulated to allow rapid, effective administration, it could be given to both donor and recipient in the setting of lung transplantation to reduce the incidence of clinically significant IRI or primary graft failure. Such an effect could have both short-term and long-term benefits in the efforts to reduce mortality after lung transplantation.
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